Although most tumor-associated antigens are not required for tumor growth, gain-of-function and shRNA-mediated knockdown experiments demonstrated the critical role of DRG-1 in the growth and proliferation of melanoma cells. This evidence concerns the gene DRG1 and neoplasm.